John Day
St. Mark's Hospital · 564 works · 18,492 citations · h-index 62
Top works
- Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)
- Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8
- Myotonic dystrophy type 2
- Genetic mapping of a second myotonic dystrophy locus
- Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA
- Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study
- Spectrin mutations cause spinocerebellar ataxia type 5
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
- CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
- Risdiplam in Type 1 Spinal Muscular Atrophy
- Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening
- Revised upper limb module for spinal muscular atrophy: Development of a new module
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort
- Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation
- Whipple's disease confined to the central nervous system